Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00703924
Show Display Options
Rank Status Study
1 Completed Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World
Condition: Cutaneous Leishmaniasis
Interventions: Drug: WR 279,396;   Drug: Placebo

Indicates status has not been verified in more than two years